ARCHIVES

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Institute Seeks White Papers On Technology

September 11, 1998

In Brief: Howley, Simone Lead Cancer Policy Board: AMA Campaign Fights Youth Smoking

November 22, 1996

In Brief: Ginder To direct Massey Cancer Center; UAB Receives $1 Million for Genetics Chair

August 15, 1997

DeMets Receives Lectureship On Epidemiology From NIH.

May 4, 2001

In Brief: David Tweardy named head of internal medicine at MD Anderson

September 19, 2014

Rep. Regula To Lead House Labor, HHS; Specter Likely Senate Labor, HHS Chairman.

January 12, 2001